Germline APOBEC3B deletion influences clinicopathological parameters in luminal-A breast cancer: evidences from a southern Brazilian cohort

[1] Burns MB(2013)APOBEC3B is an enzymatic source of mutation in breast cancer Nature 494 366-370

[2] Burns MB(2013)Evidence for APOBEC3B mutagenesis in multiple human cancers Nat Genet 45 977-983

[3] Temiz NA(2015)APOBEC3B: pathological consequences of an innate immune DNA mutator Biomed J 38 102-110

[4] Harris RS(2002)A Human Genome Diversity Cell Line Panel Science 296 261b-262

[5] Burns MB(2014)A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3′UTR enhances chromosomal DNA damage Nat Commun 112 2841-2846

[6] Leonard B(2015)APOBEC3Bexpression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation Proc Natl Acad Sci 47 1067-1072

[7] Harris RS(2015)An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers Nat Genet 12 131-124

[8] Cann HM(2019)Integrative genomic analyses of APOBEC-mutational signature, expression and germline deletion of APOBEC3 genes, and immunogenicity in multiple cancer types BMC Med Genomics 39 118-276

[9] Caval V(2020)APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy Nat Commun 142 273-284

[10] Suspène R(2018)APOBEC3A/B deletion polymorphism and cancer risk Carcinogenesis 21 274-8701

[1] Burns MB(2013)APOBEC3B is an enzymatic source of mutation in breast cancer Nature 494 366-370

[2] Burns MB(2013)Evidence for APOBEC3B mutagenesis in multiple human cancers Nat Genet 45 977-983

[3] Temiz NA(2015)APOBEC3B: pathological consequences of an innate immune DNA mutator Biomed J 38 102-110

[4] Harris RS(2002)A Human Genome Diversity Cell Line Panel Science 296 261b-262

[5] Burns MB(2014)A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3′UTR enhances chromosomal DNA damage Nat Commun 112 2841-2846

[6] Leonard B(2015)APOBEC3Bexpression in breast cancer reflects cellular proliferation, while a deletion polymorphism is associated with immune activation Proc Natl Acad Sci 47 1067-1072

[7] Harris RS(2015)An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers Nat Genet 12 131-124

[8] Cann HM(2019)Integrative genomic analyses of APOBEC-mutational signature, expression and germline deletion of APOBEC3 genes, and immunogenicity in multiple cancer types BMC Med Genomics 39 118-276

[9] Caval V(2020)APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy Nat Commun 142 273-284

[10] Suspène R(2018)APOBEC3A/B deletion polymorphism and cancer risk Carcinogenesis 21 274-8701